Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 2/20 | 0.36 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESRRG | P62508 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23366504 | 0.88 | ABCG2 (0.41) | ABCG2ESR1 | |
| SCHEMBL16525693 | 0.86 | — | — | |
| SCHEMBL23966170 | 0.80 | CARM1 (0.37) | — | |
| SCHEMBL17911345 | 0.79 | ADRB2 (0.35) | ADRB2ABCG2CNR1CNR2NPC1 | |
| SCHEMBL17911344 | 0.79 | ADRB2 (0.35) | ADRB2ABCG2CNR1CNR2NPC1 | |
| SCHEMBL16525775 | 0.78 | MAOA (0.40) | — | |
| SCHEMBL23366503 | 0.74 | KDM4E (0.39) | NPC1RAB9A | |
| SCHEMBL14189705 | 0.72 | KCNA3 (0.44) | ADRB2ESR1ESRRG | |
| SCHEMBL22179015 | 0.72 | GAA (0.37) | ABCG2 | |
| SCHEMBL22178802 | 0.71 | RAB9A (0.50) | NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3821982-B1 | SUBSTRATE FOR NUCLEIC ACID AMPLIFICATION, AND METHOD FOR MANUFACTURING SAME | KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) | 2024-07-10 | — | — | EP | disclosed |
| EP-3821981-B1 | SUBSTRATE FOR NUCLEIC ACID AMPLIFICATION, AND METHOD FOR MANUFACTURING SAME | KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) | 2024-07-10 | — | — | EP | disclosed |
| US-20210356461-A1 | CARBENE COMPOUND, CARBENE-METAL NANOPARTICLE COMPLEX AND PREPARATION METHOD THEREOF | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2021-11-18 | — | — | US | disclosed |
| US-20210229104-A1 | SUBSTRATE FOR NUCLEIC ACID AMPLIFICATION, AND METHOD FOR MANUFACTURING SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2021-07-29 | — | — | US | disclosed |
| EP-3821981-A1 | SUBSTRATE FOR NUCLEIC ACID AMPLIFICATION, AND METHOD FOR MANUFACTURING SAME | Korea Research Institute of Bioscience and Biotechnology (KR) | 2021-05-19 | — | — | EP | disclosed |
| EP-3821982-A1 | SUBSTRATE FOR NUCLEIC ACID AMPLIFICATION, AND METHOD FOR MANUFACTURING SAME | Korea Research Institute of Bioscience and Biotechnology (KR) | 2021-05-19 | — | — | EP | disclosed |
| WO-2020138982-A1 | GRAPHENE CHANNEL MEMBER COMPRISING CADAVERINE OLFACTORY RECEPTOR AND SENSOR COMPRISING SAME | 한국생명공학연구원 | 2020-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210356461-A1 | CARBENE COMPOUND, CARBENE-METAL NANOPARTICLE COMPLEX AND PREPARATION METHOD THEREOF | MB, CLTB, PARN | ADRB2 4676/4885ABCG2 4304/4885CNR1 1056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.